| Product Name | MF | CAS | Details |
|---|
| Goat anti Monkey IgG + IgA + IgM (H + L) (Alk Phos) | Details |
| EEF1A2 Blocking Peptide | Details |
| 2-[(3-Fluorophenyl)methyl]pyrrolidine | C11H14FN | 1016499-34-5 | Details |
| methyl 4-formyl-3-hydroxybenzoate | C9H8O4 | 24589-98-8 | Details |
| Sanggenone K | C30H32O6 | 86450-77-3 | Details |
| 4,4-Difluoro-1-(piperidin-4-yl)piperidine | C10H18F2N2 | 686298-08-8 | Details |
| 6-(Benzylsulfanyl)-2,3-dihydro-1H-indole-2,3-dione | C15H11NO2S | 1146290-06-3 | Details |
| 3-Phenyl-5-(pyrrolidin-2-yl)-1H-1,2,4-triazole hydrochloride | C12H15ClN4 | 1423031-50-8 | Details |
| tert-Butyl (2-(4-(aminomethyl)phenyl)propan-2-yl)carbamate | C15H24N2O2 | 2172547-31-6 | Details |
| Ferritin antibody (M89620) | Details |
| Azepane-2,5-dione | C6H9NO2 | 37637-20-0 | Details |
| FANCE Blocking Peptide | Details |
| Bradykinin [Des-Arg9] | C44H61N11O10 | 15958-92-6 | Details |
| Cyanoguanidine | C2H4N4 | 461-58-5 | Details |
| 3-Cyclobutyl-1,2,4-oxadiazole-5-carbaldehyde | C7H8N2O2 | 1492748-82-9 | Details |
| tert-Butyl N-[1-(hydroxymethyl)cyclopropyl]-N-methylcarbamate | C10H19NO3 | 387845-13-8 | Details |
| MDL 72222 | C15H17Cl2NO2 | 40796-97-2 | Details |
| p62Dok antibody | Details |
| 3-Cyclopropyl-6-methylimidazo[2,1-b][1,3]thiazole-5-carbaldehyde | C10H10N2OS | 1394042-82-0 | Details |
| 3-Hydroxy-4-methylbenzoic acid | C8H8O3 | 586-30-1 | Details |
| [2-(4-Chloro-phenylamino)-thiazol-4-yl]-acetic acid | C11H9ClN2O2S | 436094-81-4 | Details |
| 4-[(3-Methoxyphenyl)methylidene]piperidine hydrochloride | C13H18ClNO | 584555-69-1 | Details |
| (S)-Ceralasertib | C20H24N6O2S | 1352226-87-9 | Details |
| AQP4 antibody | Details |
| N-Boc-2-methyl-L-proline | C11H19NO4 | 103336-06-7 | Details |
| 3-Methoxybenzoyl chloride | C8H7ClO2 | 1711-05-3 | Details |
| 6-Hydroxyluteolin | C15H10O7 | 18003-33-3 | Details |
| GW 0742 | C21H17F4NO3S2 | 317318-84-6 | Details |
| 4-(2-Aminoethyl)-N,N-diethylaniline | C12H20N2 | 737720-20-6 | Details |
| H-Met-2-chlorotrityl resin (200-400 mesh) (Low Substitution) | Details |
| 2-(2,2-Difluoroethoxy)-5-methylaniline hydrochloride | C9H12ClF2NO | 1431968-06-7 | Details |
| 2,3-Diaminopropanenitrile dihydrochloride | C3H9Cl2N3 | 1427379-73-4 | Details |
| N-(2-Aminoethyl)ethane-1-sulfonamide hydrochloride | C4H13ClN2O2S | 1240526-14-0 | Details |
| DNAJC4 antibody | Details |
| GPRC5B antibody | Details |
| [(3-Methylphenyl)carbamoyl]formic acid | C9H9NO3 | 17738-78-2 | Details |
| Methyl 5-cyano-1H-pyrrole-2-carboxylate | C7H6N2O2 | 937-19-9 | Details |
| (PhMPhos)PdCl2, 1:1 complex with dichloromethane | Details |
| Des(2-methylbutyryl) pravastatin | C18H28O6 | 151006-03-0 | Details |
| Ethyl 2,3,4,6-tetra-O-benzyl-b-D-thiogalactopyranoside | C36H40O5S | 125411-99-6 | Details |
| 4-cyano-1-piperidinesulfonylchloride | C6H9ClN2O2S | 1392803-35-8 | Details |
| FFAR3 antibody | Details |
| Ethyl 7-hydroxypteridine-6-carboxylate | C9H8N4O3 | 90323-87-8 | Details |
| 3-Methyl-1-(oxan-4-yl)-1H-pyrazolo[3,4-b]pyridine-5-sulfonyl chloride | C12H14ClN3O3S | 1909324-80-6 | Details |
| H-LLSLTYDQK^-OH | Details |
| 2,7-Diamino-6-phenyl-4-pteridinol | C12H10N6O | 19375-89-4 | Details |
| 6-Hydroxykaempferol 3-rutinoside -6-glucoside | C33H40O21 | 145134-63-0 | Details |
| 4-CN debranone | C12H9NO3 | 1332863-97-4 | Details |
| 3-[2-Chloro-5-(trifluoromethyl)phenyl]-2-sulfanyl-3,4-dihydroquinazolin-4-one | C15H8ClF3N2OS | 380346-63-4 | Details |
| 3-(4-Bromophenyl)propionic acid | C9H9BrO2 | 1643-30-7 | Details |
| Perfluoro(2-butyltetrahydrofuran) | C8F16O | 335-36-4 | Details |
| RNF150 antibody | Details |
| Fr179642 (hydrate) | C35H54N8O21S | 1392483-15-6 | Details |
| Methyl (2S)-1-(piperidin-4-yl)pyrrolidine-2-carboxylate dihydrochloride | C11H21ClN2O2 | 1202899-22-6 | Details |
| Montelukast sodium | C35H37ClNNaO3S | 151767-02-1 | Details |
| 1-{[4-(Dimethylamino)phenyl]methyl}-1H-pyrazol-5-amine | C12H16N4 | 3524-27-4 | Details |
| H-QYIKWPWYI-OH | Details |
| 1-benzo[b]benzo[b]thiophen-2-yl-2,2-dimethylpropan-1-one | C17H16OS | 1022674-69-6 | Details |
| 4-{4-[(Dimethylamino)methyl]piperidin-1-yl}aniline | C14H23N3 | 1224932-55-1 | Details |
| 1-(2-Fluorophenyl)ethane-1-sulfonamide | C8H10FNO2S | 1250852-33-5 | Details |
| Cimifugin | C16H18O6 | 37921-38-3 | Details |
| MRPL4 antibody | Details |
| PRKAB1 Blocking Peptide | Details |
| 4,4-Diethylcyclohexan-1-amine hydrochloride | C10H22ClN | 1087747-58-7 | Details |
| 2-Chloro-N-(2-methyl-5-sulfamoylphenyl)acetamide | C9H11ClN2O3S | 904590-92-7 | Details |
| 4,5-Dimethylthiophene-3-carbaldehyde | C7H8OS | 30187-23-6 | Details |
| 3-Cyclobutylcyclobutan-1-ols | C8H14O | 1782783-08-7 | Details |
| 1-(2-Chloro-5-methoxyphenyl)piperazine hydrochloride | C11H16Cl2N2O | 740806-44-4 | Details |
| VPS52 antibody | Details |
| 4-Chloro-1H,1aH,6H,6aH-cyclopropa[A]indene-1-carboxylic acid | C11H9ClO2 | 2044796-35-0 | Details |
| 1-Ethyl-5-imino-3,4,4-trimethylimidazolidin-2-one | C8H15N3O | 1384431-34-8 | Details |
| 3-Ethylimidazolidine-2,4-dione | C5H8N2O2 | 2221-20-7 | Details |
| 5-Methyl-2-(4-methyl-1H-pyrazol-1-yl)pyridin-3-amine | C10H12N4 | 1423027-82-0 | Details |
| 4-(Pyridin-3-yl)butanoic acid hydrochloride | C9H12ClNO2 | 176446-91-6 | Details |
| tert-Butyl 3-{[(2-hydroxyethyl)sulfanyl]methyl}azetidine-1-carboxylate | C11H21NO3S | 2059937-86-7 | Details |
| 2-(1,3-Thiazol-2-yl)butan-2-amine hydrochloride | C7H13ClN2S | 1334147-82-8 | Details |
| H-SLQNSEFLL-OH | Details |
| 1,3-Dihydrospiro[indene-2,4'-oxane]-3-one | C13H14O2 | 1803586-28-8 | Details |
| 2-Methyl-1-[4-(3-methylphenyl)piperazin-1-yl]propan-2-amine | C15H25N3 | 1305785-67-4 | Details |
| IL28 antibody | Details |
| Cys(BDP630/650)-Galanin (1-30) Human | Details |
| 2-Aminopyrazolo[1,5-a]pyridine-3-carboxylic acid | C8H7N3O2 | 1542020-25-6 | Details |
| Methyl 1-(carbamoylmethyl)piperidine-4-carboxylate | C9H16N2O3 | 477862-08-1 | Details |
| UDP-D-galactosamine disodium salt | C15H25N3O16P2 | 17479-06-0 | Details |
| N-[2-(4-Bromophenyl)propan-2-yl]cyclobutanamine | C13H18BrN | 1249019-72-4 | Details |
| Ovarian Cancer Antigen (CA 125) | Details |
| 2-Nitropyridine-3-sulfonyl fluoride | C5H3FN2O4S | 1989671-97-7 | Details |
| (7-Fluoro-1-benzothiophen-2-yl)boronic acid | C8H6BFO2S | 1340599-85-0 | Details |
| (1S,3R,4R,5R)-1,3,4-Trihydroxy-6-oxabicyclo(3.2.1)octan-7-one | C7H10O5 | 665-27-0 | Details |
| H-LPRRNRWSKIWKKVVTVFS-NH2 | Details |
| Phosphorylated CHKtide | Details |
| rac-(2R,5S)-5-Methyl-2-phenylmorpholine | C11H15NO | 1350768-51-2 | Details |
| (3-Phenyloxiranyl)acetic acid cyano(6-methoxynaphthalen-2-yl)methyl ester | C23H19NO4 | 1028430-42-3 | Details |
| 5-Ethynylpyridine-3-carbonitrile | C8H4N2 | 152803-05-9 | Details |
| Methyl 2-(dimethylamino)pent-4-enoate | C8H15NO2 | 59415-13-3 | Details |
| Brr2 inhibitor C9 | C24H20N4O3S | 2104030-82-0 | Details |
| Recombinant Human CD30 Ligand | Details |
| 2-(1H-Imidazol-1-yl)-4-methylpentanoic acid | C9H14N2O2 | 1314897-50-1 | Details |
| N-(3-((4-bromo-2-methyl-5-oxo-1-phenyl-3-pyrazolin-3-yl)methoxy)phenyl)ethanamide | C19H18BrN3O3 | 1022077-48-0 | Details |
| H-NAIIK-OH | Details |
| Product Total： Product Page： | ||||
| 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 | ||||